HUMAN CHORIONIC GONADOTROPIN (HCG) MARKET OVERVIEW
Human Chorionic Gonadotropin (HCG) is a hormone produced by the placenta during pregnancy, playing a crucial role in sustaining the corpus luteum and supporting early fetal development.
MARKET SIZE AND GROWTH
01 02
MARKET SIZE (2024):
APPROXIMATELY USD 745.20
MILLION PROJECTED MARKET SIZE (2032): USD 1,324.61 MILLION
COMPOUND ANNUAL GROWTH RATE (CAGR): 6.60% DURING THE FORECAST PERIOD.
By Type
Natural Source Extraction
Recombinant DNA Technology
MARKET SEGMENTATION
By Application
Female Infertility Treatment
Oligospermic Treatment
Cryptorchidism Treatment
Others
REGIONAL ANALYSIS
Study focuses on evaluating the market landscape, consumer trends, and competition pertinent to the new product.
MIDDLE EAST & AFRICA
Emerging demand, but growth limited by economic and regulatory challenges.
NORTH AMERICA
Largest market; driven by high infertility rates and strong healthcare infrastructure.
EUROPE
Solid growth supported by widespread use of assisted reproductive technologies.
ASIA-PACIFIC
Fastest-growing region due to rising infertility and medical tourism.
KEY PLAYERS
EMD
Serono, Inc
Sanzyme
Leebio
Ferring B.V
Merck & Co., Inc
